Nicotine-induced anxiety-like behavior in a rat model of the novelty-seeking phenotype is associated with long-lasting neuropeptidergic and neuroplastic adaptations in the amygdala: Effects of the cannabinoid receptor 1 antagonist AM251

Neuropharmacology

Volumn 63, Issue 8, 2012, Pages 1335-1345

  Aydin, Cigdem ^a   Oztan, Ozge ^a   Isgor, Ceylan ^a  

^a FLORIDA ATLANTIC UNIVERSITY   (United States)

Author keywords

Amygdala; Behavioral sensitization; Cannabinoid receptor 1; Neuroplasticity; Nicotine abstinence; Social anxiety

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; BRAIN DERIVED NEUROTROPHIC FACTOR; CORTICOTROPIN RELEASING FACTOR; MESSENGER RNA; NEUROPEPTIDE Y; NICOTINE; PLACEBO; SODIUM CHLORIDE; SPINOPHILIN;

ADAPTIVE BEHAVIOR; AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG RESPONSE; DRUG SEEKING BEHAVIOR; GENE EXPRESSION; LOCOMOTION; MALE; NERVE CELL PLASTICITY; NONHUMAN; PRIORITY JOURNAL; RAT; SOCIAL PHOBIA;

AGING; AMYGDALA; ANIMALS; ANXIETY; BRAIN-DERIVED NEUROTROPHIC FACTOR; CORTICOTROPIN-RELEASING HORMONE; EXPLORATORY BEHAVIOR; IN SITU HYBRIDIZATION; INTERPERSONAL RELATIONS; MALE; MICROFILAMENT PROTEINS; MOTOR ACTIVITY; NERVE TISSUE PROTEINS; NEURONAL PLASTICITY; NEUROPEPTIDE Y; NEUROPEPTIDES; NICOTINE; NICOTINIC AGONISTS; PHENOTYPE; PIPERIDINES; PYRAZOLES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, CANNABINOID, CB1; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 84867547257     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2012.08.016     Document Type: Article

References (50)

1. P.B. Allen Functional plasticity in the organization of signaling complexes in the striatum Parkinsonism Relat. Disord. 10 5 2004 287 292
2. P.B. Allen, C.C. Ouimet, and P. Greengard Spinophilin, a novel protein phosphatase 1 binding protein localized to dendritic spines Proc. Natl. Acad. Sci. U S A 94 18 1997 9956 9961
3. C. Arévalo, R. de Miguel, and R. Hernández-Tristán Cannabinoid effects on anxiety-related behaviours and hypothalamic neurotransmitters Pharmacol. Biochem. Behav. 70 1 2001 123 131
4. C. Aydin, O. Oztan, and C. Isgor Vulnerability to nicotine abstinence-related social anxiety-like behavior: molecular correlates in neuropeptide Y, Y2 receptor and corticotropin releasing factor Neurosci. Lett. 490 3 2011 220 225
5. C. Aydin, O. Oztan, and C. Isgor Effects of a selective Y2R antagonist, JNJ-31020028, on nicotine abstinence-related social anxiety-like behavior, neuropeptide Y and corticotropin releasing factor mRNA levels in the novelty-seeking phenotype Behav. Brain Res. 222 2 2011 332 341
6. C. Aydin, O. Oztan, and C. Isgor Long-term effects of juvenile nicotine exposure on abstinence-related social anxiety-like behavior and amygdalar cannabinoid receptor 1 (CB1R) mRNA expression in the novelty-seeking phenotype Behav. Brain Res. 228 1 2012 236 239
7. G.N. Balerio, E. Aso, and R. Maldonado Role of the cannabinoid system in the effects induced by nicotine on anxiety-like behaviour in mice Psychopharmacology (Berl.) 184 3-4 2006 504 513
8. S. Bennur, B.S. Shankaranarayana Rao, R. Pawlak, S. Strickland, B.S. McEwen, and S. Chattarji Stress-induced spine loss in the medial amygdala is mediated by tissue-plasminogen activator Neuroscience 144 1 2007 8 16
9. H.C. Bergstrom, R.F. Smith, N.S. Mollinedo, and C.G. McDonald Chronic nicotine exposure produces lateralized, age-dependent dendritic remodeling in the rodent basolateral amygdala Synapse 64 10 2010 754 764
10. F.J. Bermudez-Silva, M.P. Viveros, J.M. McPartland, and F. Rodriguez de Fonseca The endocannabinoid system, eating behavior and energy homeostasis: the end or a new beginning? Pharmacol. Biochem. Behav. 95 4 2010 375 382
11. A.S. Bhatti, P. Hall, Z. Ma, R. Tao, and C. Isgor Hippocampus modulates the behaviorally-sensitizing effects of nicotine in a rat model of novelty-seeking: potential role for mossy fibers Hippocampus 17 10 2007 922 933
12. A.S. Bhatti, C. Aydin, O. Oztan, Z. Ma, P. Hall, R. Tao, and C. Isgor Effects of a cannabinoid receptor (CB) 1 antagonist AM251 on behavioral sensitization to nicotine in a rat model of novelty-seeking behavior: correlation with hippocampal 5HT Psychopharmacology (Berl.) 203 2009 23 32
13. S.R. Boikess, and J.F. Marshall A sensitizing d-amphetamine regimen induces long-lasting spinophilin protein upregulation in the rat striatum and limbic forebrain Eur. J. Neurosci. 28 10 2008 2099 2107
14. K.T. Britton, Y. Akwa, M.G. Spina, and G.F. Koob Neuropeptide Y blocks anxiogenic-like behavioral action of corticotropin-releasing factor in an operant conflict test and elevated plus maze Peptides 21 1 2000 37 44
15. K. Cahill, and M.H. Ussher Cannabinoid type 1 receptor antagonists for smoking cessation Cochrane Database Syst. Rev. 3 2011 CD005353
16. M.E. Cain, R.A. Coolon, and M.J. Gill The contribution of the central nucleus of the amygdala to individual differences in amphetamine-induced hyperactivity Behav. Brain Res. 202 1 2009 11 18
17. C. Cohen, G. Perrault, C. Voltz, R. Steinberg, and P. Soubrié SR141716, a central cannabinoid (CB(1)) receptor antagonist, blocks the motivational and dopamine-releasing effects of nicotine in rats Behav. Pharmacol. 13 5-6 2002 451 463
18. D.M. Dietz, J. Tapocik, M. Gaval-Cruz, and M. Kabbaj Dopamine transporter, but not tyrosine hydroxylase, may be implicated in determining individual differences in behavioral sensitization to amphetamine Physiol. Behav. 86 3 2005 347 355
19. M.S. Duxon, G.A. Kennett, S. Lightowler, T.P. Blackburn, and K.C. Fone Activation of 5-HT2B receptors in the medial amygdala causes anxiolysis in the social interaction test in the rat Neuropharmacology 36 4-5 1997 601 608
20. J. Feng, Z. Yan, A. Ferreira, K. Tomizawa, J.A. Liauw, M. Zhuo, P.B. Allen, C.C. Ouimet, and P. Greengard Spinophilin regulates the formation and function of dendritic spines Proc. Natl. Acad. Sci. U S A 97 16 2000 9287 9292
21. J.N. Ferguson, J.M. Aldag, T.R. Insel, and L.J. Young Oxytocin in the medial amygdala is essential for social recognition in the mouse J. Neurosci. 21 20 2001 Oct 15 8278 8285
22. A. Govindarajan, B.S. Rao, D. Nair, M. Trinh, N. Mawjee, S. Tonegawa, and S. Chattarji Transgenic brain-derived neurotrophic factor expression causes both anxiogenic and antidepressant effects Proc. Natl. Acad. Sci. U S A 103 35 2006 13208 13213
23. J. Haller, B. Varga, C. Ledent, and T.F. Freund CB1 cannabinoid receptors mediate anxiolytic effects: convergent genetic and pharmacological evidence with CB1-specific agents Behav. Pharmacol. 15 4 2004 299 304
24. M. Heilig, G.F. Koob, R. Ekman, and K.T. Britton Corticotropin-releasing factor and neuropeptide Y: role in emotional integration Trends Neurosci. 17 2 1994 80 85
25. A. Hoffman, M. Oz, R. Yang, A.H. Lichtman, and C.R. Lupica Opposing actions of chronic Δ9-tetrahydrocannabinol and cannabinoid antagonists on hippocampal long-term potentiation Learn. Mem. 14 1-2 2007 63 74
26. M.S. Hooks, G.H. Jones, A.D. Smith, D.B. Neill, and J.B. Justice Jr. Response to novelty predicts the locomotor and nucleus accumbens dopamine response to cocaine Synapse 9 1991 121 128
27. Y.Y. Huang, E.R. Kandel, and A. Levine Chronic nicotine exposure induces a long-lasting and pathway-specific facilitation of LTP in the amygdala Learn. Mem. 15 8 2008 603 610
28. Y. Ji, P.T. Pang, L. Feng, and B. Lu Cyclic AMP controls BDNF-induced TrkB phosphorylation and dendritic spine formation in mature hippocampal neurons Nat. Neurosci. 8 2005 164 172
29. M. Kabbaj, D.P. Devine, V.R. Savage, and H. Akil Neurobiological correlates of individual differences in novelty-seeking behavior in the rat: differential expression of stress-related molecules J. Neurosci. 20 18 2000 6983 6988
30. B. Le Foll, and S.R. Goldberg Rimonabant, a CB1 antagonist, blocks nicotine-conditioned place preferences Neuroreport 15 2004 2139 2143
31. B. Le Foll, B. Forget, H.J. Aubin, and S.R. Goldberg Blocking cannabinoid CB1 receptors for the treatment of nicotine dependence: insights from pre-clinical and clinical studies Addict. Biol. 13 2 2008 239 252
32. I.S. McGregor, F.N. Dastur, R.A. McLellan, and R.E. Brown Cannabinoid modulation of rat pup ultrasonic vocalizations Eur. J. Pharmacol. 313 1-2 1996 43 49
33. D.K. Miller, L.H. Wilkins, M.T. Bardo, P.A. Crooks, and L.P. Dwoskin Once weekly administration of nicotine produces long-lasting locomotor sensitization in rats via a nicotinic receptor-mediated mechanism Psychopharmacology (Berl.) 156 2001 469 476
34. R. Mitra, and R.M. Sapolsky Expression of chimeric estrogen- glucocorticoid-receptor in the amygdala reduces anxiety Brain Res. 1342 2010 33 38
35. R. Mitra, S. Jadhav, B.S. McEwen, A. Vyas, and S. Chattarji Stress duration modulates the spatiotemporal patterns of spine formation in the basolateral amygdala Proc. Natl. Acad. Sci. U S A 102 26 2005 9371 9376
36. M. Navarro, E. Hernández, R.M. Muñoz, I. del Arco, M.A. Villanúa, M.R. Carrera, and F. Rodríguez de Fonseca Acute administration of the CB1 cannabinoid receptor antagonist SR 141716A induces anxiety-like responses in the rat Neuroreport 8 2 1997 491 496
37. J. Prange-Kiel, L. Fester, L. Zhou, H. Jarry, and G.M. Rune Estrus cyclicity of spinogenesis: underlying mechanisms J. Neural Transm. 116 11 2009 1417 1425
38. R.J. Rodgers, J. Haller, J. Halasz, and E. Mikics 'One-trial sensitization' to the anxiolytic-like effects of cannabinoid receptor antagonist SR141716A in the mouse elevated plus-maze Eur. J. Neurosci. 17 6 2003 1279 1286
39. R.J. Rodgers, P.M. Evans, and A. Murphy Anxiogenic profile of AM-251, a selective cannabinoid CB1 receptor antagonist, in plus-maze-naïve and plus-maze-experienced mice Behav. Pharmacol. 16 5-6 2005 405 413
40. T. Rubino, N. Realini, C. Castiglioni, C. Guidali, D. Viganó, E. Marras, S. Petrosino, G. Perletti, M. Maccarrone, V. Di Marzo, and D. Parolaro Role in anxiety behavior of the endocannabinoid system in the prefrontal cortex Cereb. Cortex 18 6 2008 1292 1301
41. T.J. Sajdyk, A. Shekhar, and D.R. Gehlert Interactions between NPY and CRF in the amygdala to regulate emotionality Neuropeptides 38 4 2004 225 234
42. T.J. Sajdyk, S.D. Fitz, and A. Shekhar The role of neuropeptide Y in the amygdala on corticotropin-releasing factor receptor-mediated behavioral stress responses in the rat Stress 9 1 2006 21 28
43. D. Sarrouilhe, A. di Tommaso, T. Métayé, and V. Ladeveze Spinophilin: from partners to functions Biochimie 88 9 2006 1099 1113
44. S. Sheriff, F.M. Dautzenberg, J.J. Mulchahey, M. Pisarska, R.L. Hauger, W.T. Chance, A. Balasubramaniam, and J.W. Kasckow Interaction of neuropeptide Y and corticotropin-releasing factor signaling pathways in AR-5 amygdalar cells Peptides 22 12 2001 2083 2089
45. K.S. Sink, K.N. Segovia, J. Sink, P.A. Randall, L.E. Collins, M. Correa, E.J. Markus, V.K. Vemuri, A. Makriyannis, and J.D. Salamone Potential anxiogenic effects of cannabinoid CB1 receptor antagonists/inverse agonists in rats: comparisons between AM4113, AM251, and the benzodiazepine inverse agonist FG-7142 Eur. Neuropsychopharmacol. 20 2 2010 112 122
46. C.J. Slawecki, A.K. Thorsell, A. El Khoury, A.A. Mathé, and C.L. Ehlers Increased CRF-like and NPY-like immunoreactivity in adult rats exposed to nicotine during adolescence: relation to anxiety-like and depressive-like behavior Neuropeptides 39 4 2005 369 377
47. N. Suto, J.D. Austin, and P. Vezina Locomotor response to novelty predicts a rat's propensity to self-administer nicotine Psychopharmacology (Berl.) 158 2 2001 175 180
48. US Food and Drug Administration Advisory Committee FDA Briefing Document: Zimulti (Rimonabant) Tablets, 20 mg FDA, Rockville, 2007 http://www.fda.gov/ OHRMS/DOCKETS/AC/07/briefing/2007-4306b1-00-index.htm.
49. M.P. Viveros, E.M. Marco, R. Llorente, and M. López-Gallardo Endocannabinoid system and synaptic plasticity: implications for emotional responses Neural Plast. 2007 2007 52908
50. R. Zhou, S. Wang, and X. Zhu Prenatal ethanol exposure attenuates GABAergic inhibition in basolateral amygdala leading to neuronal hyperexcitability and anxiety-like behavior of adult rat offspring Neuroscience 170 3 2010 749 757